Neste trabalho foi investigada a ação fotodinâmica dos pró-fármacos 5-ALA e 8-ALA incorporados em nanopartículas de quitosana, através da incidência de luz em células de melanoma, utilizando sinergicamente a Eletroquimioterapia e a Terapia Fotodinâmica. O ácido 5-aminolevulínico (5-ALA) e seus ésteres derivados são precursores metabólicos da protoporfirina IX (PpIX) e apresentam uma penetração limitada no estrato córneo. Portanto, o objetivo desse trabalho foi desenvolver, caracterizar e avaliar o efeito fotodinâmico das nanopartículas de quitosana contendo os pró-fármacos 5-ALA e seu éster derivado 8-ALA e investigar a produção efetiva de PpIX. Concomitantemente, o efeito sinérgico da Eletroquimioterapia (ECT) com a TFD também foi estudado com a finalidade de aumentar a permeação dos fármacos fotossensibilizantes através da pele, aumentando a eficiência da TFD no tratamento de neoplasias cutâneas. As nanopartículas de quitosana foram obtidas pelo método de gelificação ionotrópica, produzindo nanopartículas em tamanho nanométrico (636,0 nm ± 6,5), com uma distribuição de tamanho homogênea (0,37), além de apresentar um potencial zeta significantemente positivo + 35,3 mV (± 2,21). Seu perfil de liberação e capacidade de incorporação de 80% dos pró-fármacos também foi determinado. Os estudos de citotoxicidade na ausência de luz demonstraram o caráter biocompatível das nanopartículas de quitosana desenvolvidas, assim como a produção significativa de PpIX e foi possível comprovar o excelente efeito fototóxico da formulação desenvolvida. Os estudos de sinergismo da ECT com a TFD comprovaram que a combinação das nanopartículas de quitosana contendo os pró-fármacos, com aplicação de microcorrentes de 400 ?A e dose de luz de 3 J/cm2, nestas condições apresentou uma morte celular significativa. / This study investigated the photodynamic action of the prodrug 5-ALA and 8-ALA into chitosan nanoparticles, through the light incidence in melanoma cells, using synergistically the Electrochemotherapy and Photodynamic Therapy. The 5- aminolevulinic acid (5-ALA) and its ester derivatives are metabolic precursors of protoporphyrin IX (PpIX) and have a limited penetration in the stratum corneum. Therefore, the objective of this study was to develop, characterize and evaluate the photodynamic effect of chitosan nanoparticles containing the prodrug 5-ALA and its ester derivative 8-ALA. Besides, was investigated the effective production of PpIX. Concomitantly, the synergistic effect of Electrochemotherapy (ECT) with PDT was also studied for the purpose of increasing the permeation of drugs through the skin, enhancing the efficiency of the PDT in the treatment of skin cancers. Chitosan nanoparticles were obtained by the ionotropic gelation producing nanoparticles in nanosize (636.0 ± 6.5 nm), with a homogenous size distribution (0.37), and present a significantly positive zeta potential + 35.3 mV (± 2.21). Release profile and ability to incorporate 80% of the prodrug was also determined. The cytotoxicity studies demonstrated in the absence of light the biocompatible nature of chitosan nanoparticles developed, as well as the significant production of PpIX and it was possible to demonstrate the excellent effect of phototoxic formulation developed. The synergism studies of ECT with PDT have shown that the combination of chitosan nanoparticles containing prodrugs, applying microcurrents 400 ?A and light dose of 3 J/cm2 under these conditions showed a significant cell death.

Línguas eletrônicas constituídas de filmes nanoestruturados depositados sobre eletrodos metálicos, e empregando a técnica de espectroscopia de impedância como princípio de detecção, vêm apresentando excelentes resultados para a diferenciação de substâncias que constituem os paladares básicos e na detecção de impurezas em amostras líquidas. A principal limitação para o uso comercial é a necessidade da substituição das unidades sensoriais do arranjo, que necessita de recalibração. Nesta tese introduzimos um novo arranjo de unidades sensoriais, constituídos de eletrodos de cromo eletrodepositados, que não necessitam de filmes finos. Usando arranjos de cinco ou dez unidades sensoriais nominalmente idênticas, obtivemos uma língua eletrônica capaz de detectar paladares básicos e íons de cobre em água em concentrações abaixo de 1μM. As diferenças nas respostas elétricas dos eletrodos são oriundas das diferenças na sua morfologia. A alta sensibilidade apresentada foi explorada na análise de vinhos e amostras de águas coletadas de vários rios e lagos. Similarmente às línguas eletrônicas com filmes nanoestruturados, o arranjo sensorial de eletrodos de cromo foi capaz de distinguir vinhos de uma mesma varietal e produtor, mas de diferentes safras, e de um mesmo produtor e safra, mas de diferentes varietais. Tentamos também melhorar o desempenho das línguas eletrônicas combinando unidades constituídas de filmes finos de quitosana e poli(o-etoxianilina). Apesar do interesse nas propriedades advindas da interação entre esses materiais, especialmente quando a quitosana foi utilizada na forma de nanopartículas, o desempenho foi similar ao da língua eletrônica contendo eletrodos de cromo sem filmes. / Electronic tongues based on nanostructured films and employing impedance spectroscopy as the principle of detection have proven excellent to distinguish between basic tastes and detect trace amounts of impurities in liquid samples. The main limitation for a commercial use, though, is the need to replace the sensing units of the sensor array, which requires recalibration, owing to the relatively poor stability of the nanostructured films. In this thesis we introduce a new arrangement for the sensing units, which are produced from electrodeposited chrome electrodes, with no need to adsorb an organic film. Using an array with 5 or 10 nominally identical chrome electrodes, we obtained an electronic tongue capable of detecting basic tastes and copper ions in water down to the 1μM level. The differences in electrical properties for the electrodes arose from differences in morphology. Furthermore, this high sensitivity could be exploited in the analysis of wines, and water samples collected from various rivers and lakes. Similarly to electronic tongues made with nanostructured films, the sensor array with electrodeposited chrome electrodes was capable of distinguishing wines from the same grape and producer, but different vintages, or from the same producer and vintage but different grapes. We also attempted to optimize the performance of electronic tongues by combining sensing units made of chitosan and poly(o-ethoxyaniline). In spite of the interesting properties deriving from the interaction between these components, especially when chitosan nanoparticles were used, the performance of the sensor array was similar to that of the electronic tongue obtained with bare chrome electrodes.

Previous studies have demonstrated that chitosan and its derivative, N-trimethyl chitosan chloride (TMC) are effective and safe absorption enhancers to improve mucosal delivery of macromolecular drugs including vaccines. Furthermore, chitosan and TMC can easily form microparticles and nanoparticles, which have the ability to encapsulate large amounts of antigens. Emzaloid™ technology has proven in the past to be an effective delivery system for numerous drugs. Emzaloids can entrap, transport and deliver large amounts of drugs including vaccines. In this study, the ability of chitosan microparticles and nanoparticles, TMC microparticles as well as micrometer and nanometer range Emzaloids to enhance both the systemic and mucosal (local) immune response against diphtheria toxoid (DT) after nasal administration in mice was investigated. The above mentioned formulations were prepared and characterised according to size and morphology. DT was then associated to the chitosan microparticles and nanoparticles as well as TMC microparticles to determine the antigen loading and release. It was found that the loading efficacy of the formulations was 88.9 %, 27.74 % and 63.1 % respectively, and the loading capacity of the formulations was 25.7 %, 8.03 % and 18.3 %. DT loaded and unloaded (empty) chitosan microparticles and nanoparticles, TMC microparticles, micrometer and nanometer range Emzaloids as well as DT in phosphate buffered saline (PBS) were administered nasally to mice. Mice were also vaccinated subcutaneous with DT associated to alum as a positive control. All mice were vaccinated on three consecutive days in week 1 and boosted in week 3. Sera was analysed for anti- DT IgG and nasal lavages were analysed for anti-DT IgA using an enzyme linked imrnunosorbent assay (ELISA). In the study conducted to determine the systemic (IgG) and local (IgA) immune responses it was seen that DT associated to all the experimental formulations produced a systemic immune response. The said formulations produced a significantly higher systemic immune response when compared to the formulation of DT in PBS. Furthermore, the mice vaccinated with DT associated to the TMC formulations showed a much higher systemic immune response than the mice that were vaccinated subcutaneously with DT associated to alum, whereas the other formulations produced systemic immune responses that were comparable to that of DT associated to alum. It was also found that DT associated to the experimental formulations produced a local immune response, however only DT associated to TMC microparticles produced a consistent local immune response. It can be concluded from the in vivo experiments that the TMC formulations, moreover, the TMC microparticles is the most effective and promising formulation for the nasal delivery of vaccines. / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2005.

Previous studies have demonstrated that chitosan and its derivative, N-trimethyl chitosan chloride (TMC) are effective and safe absorption enhancers to improve mucosal delivery of macromolecular drugs including vaccines. Furthermore, chitosan and TMC can easily form microparticles and nanoparticles, which have the ability to encapsulate large amounts of antigens. Emzaloid™ technology has proven in the past to be an effective delivery system for numerous drugs. Emzaloids can entrap, transport and deliver large amounts of drugs including vaccines. In this study, the ability of chitosan microparticles and nanoparticles, TMC microparticles as well as micrometer and nanometer range Emzaloids to enhance both the systemic and mucosal (local) immune response against diphtheria toxoid (DT) after nasal administration in mice was investigated. The above mentioned formulations were prepared and characterised according to size and morphology. DT was then associated to the chitosan microparticles and nanoparticles as well as TMC microparticles to determine the antigen loading and release. It was found that the loading efficacy of the formulations was 88.9 %, 27.74 % and 63.1 % respectively, and the loading capacity of the formulations was 25.7 %, 8.03 % and 18.3 %. DT loaded and unloaded (empty) chitosan microparticles and nanoparticles, TMC microparticles, micrometer and nanometer range Emzaloids as well as DT in phosphate buffered saline (PBS) were administered nasally to mice. Mice were also vaccinated subcutaneous with DT associated to alum as a positive control. All mice were vaccinated on three consecutive days in week 1 and boosted in week 3. Sera was analysed for anti- DT IgG and nasal lavages were analysed for anti-DT IgA using an enzyme linked imrnunosorbent assay (ELISA). In the study conducted to determine the systemic (IgG) and local (IgA) immune responses it was seen that DT associated to all the experimental formulations produced a systemic immune response. The said formulations produced a significantly higher systemic immune response when compared to the formulation of DT in PBS. Furthermore, the mice vaccinated with DT associated to the TMC formulations showed a much higher systemic immune response than the mice that were vaccinated subcutaneously with DT associated to alum, whereas the other formulations produced systemic immune responses that were comparable to that of DT associated to alum. It was also found that DT associated to the experimental formulations produced a local immune response, however only DT associated to TMC microparticles produced a consistent local immune response. It can be concluded from the in vivo experiments that the TMC formulations, moreover, the TMC microparticles is the most effective and promising formulation for the nasal delivery of vaccines. / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2005.

Submitted by Aelson Maciera (aelsoncm@terra.com.br) on 2017-03-22T19:16:28Z No. of bitstreams: 1 DissTTB.pdf: 2398693 bytes, checksum: 0a0148927746ba0af71705e6c51cb65e (MD5) / Approved for entry into archive by Ronildo Prado (ronisp@ufscar.br) on 2017-03-22T19:21:20Z (GMT) No. of bitstreams: 1 DissTTB.pdf: 2398693 bytes, checksum: 0a0148927746ba0af71705e6c51cb65e (MD5) / Approved for entry into archive by Ronildo Prado (ronisp@ufscar.br) on 2017-03-22T19:21:41Z (GMT) No. of bitstreams: 1 DissTTB.pdf: 2398693 bytes, checksum: 0a0148927746ba0af71705e6c51cb65e (MD5) / Made available in DSpace on 2017-03-22T19:26:28Z (GMT). No. of bitstreams: 1 DissTTB.pdf: 2398693 bytes, checksum: 0a0148927746ba0af71705e6c51cb65e (MD5) Previous issue date: 2016-02-26 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Empresa Brasileira de Pesquisa Agropecuária (EMBRAPA) / The production of biodegradable films based on renewable low cost resources has increased considerably. The research and development of new materials in this segment make possible to replace, even still partially, the synthetic plastics derived from petrol and to add value to agro-industrial waste and agricultural commodities. The fruit purees (or pulp) represent an alternative for obtaining these low-cost arrays. It can be obtained from the fruit itself or from its processing wastes. Amongst the suited fruits for this purpose is the papaya (Carica papaya), largely available. Brazil is the largest producer of this fruit and, due to its high perishability, is a rich source of waste material for pulp and edible film processing. Although the films prepared from fruit puree lacks in mechanical and permeability properties, such features may be minimized by the addition of nanofillers associated to film forming biopolymers. Thus, the evaluation of papaya puree, in over-ripe stage, as raw material for film processing using a Mathis System (in batch mode) with reinforced nanostructure was the main aim of this study. The films were characterized considering mechanical and thermal properties, permeability, colorimetric and antimicrobial activity. The best results were recorded to formulations in which the pectin was added at 0.5 % (w/v), increasing the maximum fracture strength (σmax), in 12 times when compared to neat puree films (control). The insertion of cellulose nanofibers and chitosan nanoparticles also promoted a σmax increasing, nevertheless in inferior proportion (6.2 and 5 times respectively). The presence of pectin also was positive in reducing the permeability rates (WVP) with values of 77.72 % lower than those measured to the control films. Concerning the colorimetric properties, the films with filler additions (chitosan nanoparticles with glycerol) suffered the greater color changes (ΔE). The addition of chitosan nanoparticles also speed the surface browning index (BI). Again the pectin acted positively in preserving the original color characteristics. The antimicrobial essays indicated that the chitosan in nanoparticle format inside the polymeric matrix did not present any antimicrobial activity. The over-ripe papaya pulp showed to be a raw material suitable for edible biodegradable film processing and the addition of nanofillers and pectin necessary to improve the barrier and mechanical properties and to preserve the original colorimetric features. / A produção de filmes biodegradáveis baseados em recursos renováveis, fazendo uso de matrizes biopoliméricas de baixo custo, vem aumentando consideravelmente. A pesquisa e o desenvolvimento de novos materiais neste segmento possibilitam a substituição, ainda que parcial, dos plásticos sintéticos derivados do petróleo, além de agregar valor a resíduos agroindustriais e commodities agrícolas. Os purês de frutas (ou polpa) representam uma alternativa viável para a obtenção destas matrizes, podendo ser empregados a própria fruta ou rejeitos provenientes de seu processamento. Dentre os frutos adequados para este fim está o mamão papaia (Carica papaya), fartamente disponível no país. O Brasil é seu maior produtor mundial e, devido à sua alta perecividade, é uma fonte rica de rejeitos adequados à produção de polpas e ao processamento de filmes comestíveis. Embora os filmes processados a partir de purê de frutas apresentem limitações mecânicas e de permeabilidade, estas características podem ser minimizadas pela formação de compósitos através da inserção de nanoestruturas de reforço e associação com outros biopolímeros com características filmogênicas. Assim, avaliar o uso de polpas de mamão papaia, em adiantado estado de maturação no processamento de filmes em Sistema Mathis (no modo batelada) e o efeito da inserção de estruturas de reforço, foram os principais objetivos deste trabalho. Os filmes foram caracterizados quanto às suas propriedades mecânicas, térmica, de permeabilidade, colorimétrica e antimicrobiana. Os melhores resultados foram obtidos para as composições em que a pectina foi adiciona em 0,5 % (m/v), elevando a tensão máxima de ruptura (σmax), em 12 vezes quando comparada aos filmes de polpa sem aditivos (controle). A adição de nanofibras de celulose e a nanopartículas de quitosana também melhoraram σmax, mas em valores inferiores (6,2 e 5 vezes respectivamente). A inserção da pectina também foi favorável na redução das taxas de permeabilidade (WVP) com valores 77,72 % inferiores aos filmes controle. Com relação às medidas colorimétricas, as maiores alterações registradas foram para os filmes processados com os reforços (quitosana em conjunto com o glicerol), os quais resultaram em uma maior variação total de cor (ΔE). A presença de nanopartículas de quitosana também acelerou o escurecimento superficial (IE). A adição de pectina nas formulações atuou positivamente na preservação das características colorimétricas iniciais. Os testes antimicrobianos indicaram que a quitosana na forma de nanopartículas inseridas na matriz biopolimérica não apresentou atividade antimicrobiana. A polpa de mamão papaia, na condição sobremadura, mostrou ser uma matéria-prima adequada ao processamento de filmes comestíveis biodegradáveis e a adição de nanoreforços e de pectina necessárias para a melhoria das propriedades mecânicas e de barreira e para a preservação das características colorimétricas iniciais dos filmes.

The subject of the thesis is study of possible applications of isoform of glutamic acid polymer (-PGA). The theoretical part is focused on the properties of this biopolymer and potential applications in various areas. Producers and mechanisms of biosynthesis are also mentioned. In the experimental part, the polymer was firstly characterised by following methods: FT-IR spectroscopy, TGA, DSC and SEC-MALS. Its isoelectric point, antimicrobial activity and solubility in various solvents were also determined. The biopolymer was also precipitated by divalent cations and its interaction with oppositely charged CTAB surfactant was studied. The main experimental study was researching the effect of -PGA on viability of Saccharomyces cerevisiae and Lactobacillus rhamnosus under stress conditions by flow cytometry. The performed stresses included ethanol exposure, high temperature and freezing stress, in which its effects were compared to conventional cryoprotectants. The cells of the mentioned microorganisms were also stressed osmotically and exposed to model gastrointestinal juices - gastric, pancreatic and bile. The protective effects of -PGA on the cells were recorded in ethanol stress on Lactobacillus rhamnosus. Its excellent cryoprotection properties were confirmed and its protective effect of gastric juice exposure on Saccharomyces cerevisiae cells was also observed. At the end of the experimental part, -PGA/alginate beads suitable for encapsulation of probiotic bacteria and -PGA/chitosan nanoparticles for encapsulation of biologically active substances.

La thérapie génique représente l'un des défis de la médecine des prochaines décennies dont la réussite dépend de la capacité d'acheminer l'ADN thérapeutique jusqu'à sa cible. Des structures non virales ont été envisagées, dont le chitosane, polymère cationique qui se combine facilement à l’ADN. Une fois le complexe formé, l’ADN est protégé des nucléases qui le dégradent. Le premier objectif de l'étude est de synthétiser et ensuite évaluer différentes nanoparticules de chitosane et choisir la mieux adaptée pour une efficacité de transfection sélective in vitro dans les cellules carcinomes épidermoïdes (KB). Le deuxième objectif de l'étude est d'examiner in vivo les effets protecteurs du gène de l'IL-1Ra (bloqueur naturel de la cytokine inflammatoire, l’Interleukine-1β) complexé aux nanoparticules de chitosane sélectionnées dans un modèle d'arthrite induite par un adjuvant (AIA) chez le rat. Les nanoparticules varient par le poids moléculaire du chitosane (5, 25 et 50 kDa), et la présence ou l’absence de l’acide folique (FA). Des mesures macroscopiques de l’inflammation seront évaluées ainsi que des mesures de concentrations de l’Interleukine-1β, Prostaglandine E2 et IL-1Ra humaine secrétés dans le sérum. Les nanoparticules Chitosane-ADN en présence de l’acide folique et avec du chitosane de poids moléculaire de 25 kDa, permettent une meilleure transfection in vitro. Les effets protecteurs des nanoparticules contenant le gène thérapeutique étaient évidents suite à la détection de l’IL-1Ra dans le sérum, la baisse d'expressions des facteurs inflammatoires, l’Interleukine-1 et la Prostaglandine-E2 ainsi que la diminution macroscopique de l’inflammation. Le but de cette étude est de développer notre méthode de thérapie génique non virale pour des applications cliniques pour traiter l’arthrite rhumatoïde et d’autres maladies humaines. / Considered to be one of the medical challenges of the coming decade, the success of gene therapy depends on the ability to deliver therapeutic DNA to target cells. Non-viral polymers, such as chitosan (Ch), a cationic polymer, can be easily combined with DNA. Once a complex is formed, DNA is protected from degradation by nucleases. The first objective of this study was to define the characteristics of the best-suited Ch nanoparticle for maximum selective transfection in human epidermoid carcinoma (KB) cells in vitro. Nanoparticles varied by the presence or absence of folic acid (FA) and Ch’s molecular weight (MW 5, 25 and 50 kDa). They were then selected and combined with interleukin-1 receptor antagonist (IL-1Ra) gene, a natural blocker of the inflammatory cytokine interleukin-1beta (IL-1β). The second objective was to inject these carriers by the hydrodynamic method in a rat model of adjuvant-induced arthritis and to evaluate the inhibitory effects of IL-1Ra against inflammation in vivo. Ch-DNA nanoparticles with FA and Ch25 demonstrated selective transfection and significantly increased it in KB cells in vitro. The inhibitory effects of IL-1Ra gene therapy in vivo were evident from lower expression levels of inflammatory factors (IL-1 and prostaglandin E2) and decreased macroscopic limb inflammation. The results also revealed the presence of human recombinant IL-1Ra protein in rat sera. Non-viral gene therapy with Ch-PEG-FA-DNA nanoparticles containing the IL-1Ra gene appears to significantly decrease inflammation in this experimental model of arthritis.

The present thesis focuses on the selection of polymers and methods to fabricate stable and stimuli responsive multilayer self-assembly via layer-by-layer (LbL) approach. The polymers utilized in this study are biodegradable and biocompatible such as hyaluronic acid, chitosan and poly(vinyl alcohol) (PVA). The thesis is comprised of six chapters and a brief discussion on the contents of the individual chapters is given below. Chapter I reviews the LbL self-assembly approach in the context of drug delivery. The various interactions such as electrostatic, hydrogen bonding and covalent bonding involved in preparation of stable multilayer assemblies via LbL approach are discussed. Stimuli responsive behaviour of these multilayer assemblies can be tuned by choosing suitable depositing materials and method. Preparation of hollow microcapsules using LbL approach and its application in drug delivery has also been described in this chapter. Chapter II deals with the LbL assembly of a neutral polymer, poly(vinyl alcholol) (PVA). The negative charge on PVA backbone was induced by physical cross-linking with borax. The PVA-borate can undergo electrostatic interaction with positively charged chitosan in LbL process to form multilayer thin film. The thin film of PVA-borate complex/chitosan was found be responsive towards glucose concentration; disintegration of the multilayer assembly was observed at a high glucose concentration. This finding was rationalized on the basis of strong interaction of glucose with borate ions leading to dissociation of PVA-borate complex and subsequent collapse of the assembly. Thus, this multilayer self-assembly is potent for glucose triggered drug delivery. Chapter III reports the construction of a stable hydrogen bonded multilayer self-assembly based on complementary DNA base pairs (adenine and thymine) interaction. The natural polymer such as chitosan was modified with adenine whereas hyaluronic acid was modified with thymine. These two modified polymers were sequentially deposited on flat substrate and melamine formaldehyde (MF) particles; wherein strong interaction among the DNA base pairs led to the formation of stable assembly without utilizing any external cross-linking agent. The modified polymers are non-cytotoxic as proved from MTT assay. Further the multilayer assembly was used for pH responsive anticancer drug doxorubicin hydrochloride (DOX) release. In Chapter IV, glutaraldehyde mediated LbL self-assembly of single polymer multilayer thin films on flat and colloidal substrate by covalent bonding is described. A comparitive study between the native polymer (chitosan) and adenine modified polymer in the growth of thin film is performed. It is established from the study that the conformation of polymer and the availability of cross-linking points on the polymer play a crucial role in controlling the growth of these multilayer assemblies. Chapter V is divided into two parts (A and B). Part A describes a simple and unique protocol for fabrication of water dispersed chitosan nanoparticles (CH NPs). The method utilized in this work is based on the fast desolvation technique without using any additional stabilizer or any sophisticated instrumental setup. Furthermore, the CH NPs prepared from the mentioned protocol were proved to be cell-viable and are found to be responsive towards pH of the solution. In part B of this chapter, the LbL self-assembly of the responsive CH NPs is fabricated via electrostatic interaction with hyaluronic acid (HA). The growth of the multilayer thin film was found to be linear as function of number of bilayers. The morphology of thin film was characterized by atomic force microscopy (AFM) and scanning electron microscopy (SEM). The microscopic images reveal the uniform film morphology devoid of any phase separation of nanoparticles and polymers. Subsequently, the film was loaded with an anticancer therapeutic, doxorubicin hydrochloride (DOX). The release dynamics of encapsulated drug from the self-assembly are tunable and pH responsive. Chapter VI deals with the general and versatile method for the encapsulation of hydrophobic model drugs into polymeric multilayer assembly by using LbL approach. Electrical charge was induced on the surface of pyrene (uncharged organic substance) using an amphiphilic surfactant, sodium dodecyl sulfate (SDS) by micellar solubilization. The SDS micellar solution of pyrene was utilized to grow LbL multilayer thin film on a planar substrate and colloidal particles along with chitosan as a polycation. The LbL self-assembly of pyrene loaded SDS micelles/chitosan is additionally able to encapsulate hydrophobic or hydrophilic model therapeutics, thus providing an opportunity for dual-drug delivery. The desorption kinetics of the two model drugs from the thin film is found to follow a second order rate model.

La thérapie génique représente l'un des défis de la médecine des prochaines décennies dont la réussite dépend de la capacité d'acheminer l'ADN thérapeutique jusqu'à sa cible. Des structures non virales ont été envisagées, dont le chitosane, polymère cationique qui se combine facilement à l’ADN. Une fois le complexe formé, l’ADN est protégé des nucléases qui le dégradent. Le premier objectif de l'étude est de synthétiser et ensuite évaluer différentes nanoparticules de chitosane et choisir la mieux adaptée pour une efficacité de transfection sélective in vitro dans les cellules carcinomes épidermoïdes (KB). Le deuxième objectif de l'étude est d'examiner in vivo les effets protecteurs du gène de l'IL-1Ra (bloqueur naturel de la cytokine inflammatoire, l’Interleukine-1β) complexé aux nanoparticules de chitosane sélectionnées dans un modèle d'arthrite induite par un adjuvant (AIA) chez le rat. Les nanoparticules varient par le poids moléculaire du chitosane (5, 25 et 50 kDa), et la présence ou l’absence de l’acide folique (FA). Des mesures macroscopiques de l’inflammation seront évaluées ainsi que des mesures de concentrations de l’Interleukine-1β, Prostaglandine E2 et IL-1Ra humaine secrétés dans le sérum. Les nanoparticules Chitosane-ADN en présence de l’acide folique et avec du chitosane de poids moléculaire de 25 kDa, permettent une meilleure transfection in vitro. Les effets protecteurs des nanoparticules contenant le gène thérapeutique étaient évidents suite à la détection de l’IL-1Ra dans le sérum, la baisse d'expressions des facteurs inflammatoires, l’Interleukine-1 et la Prostaglandine-E2 ainsi que la diminution macroscopique de l’inflammation. Le but de cette étude est de développer notre méthode de thérapie génique non virale pour des applications cliniques pour traiter l’arthrite rhumatoïde et d’autres maladies humaines. / Considered to be one of the medical challenges of the coming decade, the success of gene therapy depends on the ability to deliver therapeutic DNA to target cells. Non-viral polymers, such as chitosan (Ch), a cationic polymer, can be easily combined with DNA. Once a complex is formed, DNA is protected from degradation by nucleases. The first objective of this study was to define the characteristics of the best-suited Ch nanoparticle for maximum selective transfection in human epidermoid carcinoma (KB) cells in vitro. Nanoparticles varied by the presence or absence of folic acid (FA) and Ch’s molecular weight (MW 5, 25 and 50 kDa). They were then selected and combined with interleukin-1 receptor antagonist (IL-1Ra) gene, a natural blocker of the inflammatory cytokine interleukin-1beta (IL-1β). The second objective was to inject these carriers by the hydrodynamic method in a rat model of adjuvant-induced arthritis and to evaluate the inhibitory effects of IL-1Ra against inflammation in vivo. Ch-DNA nanoparticles with FA and Ch25 demonstrated selective transfection and significantly increased it in KB cells in vitro. The inhibitory effects of IL-1Ra gene therapy in vivo were evident from lower expression levels of inflammatory factors (IL-1 and prostaglandin E2) and decreased macroscopic limb inflammation. The results also revealed the presence of human recombinant IL-1Ra protein in rat sera. Non-viral gene therapy with Ch-PEG-FA-DNA nanoparticles containing the IL-1Ra gene appears to significantly decrease inflammation in this experimental model of arthritis.